Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative-Reference-Cited by-同舟云学术

Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative

Published:2024-01 Issue:1 Volume:15 Page:101611
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Galvin Angéline,Soubeyran Pierre,Brain Etienne,Cheung Kwok-Leung,Hamaker Marije E.,Kanesvaran Ravindran,Mauer Murielle,Mohile Supriya,Montroni Isacco,Puts Martine,Rostoft Siri,Wildiers Hans,Mathoulin-Pélissier Simone,Bellera Carine

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference165 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. An Aging World: 2015;He,2016

3. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions;Sedrak;CA Cancer J Clin,2021

4. Changes in the use of end points in clinical trials for elderly cancer patients over time;Le Saux;Ann Oncol,2017

5. Article commentary: patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs);Weldring;Health Serv Insights,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcomes to Achieve Person-Centered Care for Aging People With Kidney Disease;Seminars in Nephrology;2024-08

2. Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%;Frontiers in Immunology;2024-02-23